Psychiatric Rehabilitation In Prophylaxis Of Migraine – A Systematic Review.
DOI:
https://doi.org/10.69980/ajpr.v28i1.135Keywords:
Migraine, psychological, behavioural therapy, psychiatric RehabilitationAbstract
Background: Migraine affects approximately 15% of the global population, resulting in significant disability and decreased quality of life. Traditional pharmacological treatments, while effective, often overlook the psychosocial dimensions of the disorder. This systematic review evaluates the effectiveness of psychiatric rehabilitation techniques, specifically cognitive-behavioral therapy (CBT) and mindfulness-based stress reduction (MBSR), in migraine prophylaxis.
Methods: A comprehensive literature search was conducted across electronic databases, including PubMed and Cochrane Library, from January 2000 to January 2025. Studies included were randomized controlled trials, cohort studies, and case-control studies focusing on adults diagnosed with migraines undergoing CBT or MBSR, with outcomes measuring migraine frequency and severity, as well as psychological symptoms.
Results: A total of 15 studies (1,200 participants) were included. CBT demonstrated a significant effect size (Cohen's d = 0.65) in reducing migraine frequency and improving quality of life, alongside benefits in co-morbid psychological symptoms. MBSR also achieved a moderate effect size (Cohen's d = 0.52) for decreasing migraine frequency and enhancing emotional regulation. Multimodal approaches combining CBT with physical therapy showed additional benefits in migraine management.
Conclusions: This review supports the integration of psychiatric rehabilitation techniques into comprehensive migraine management plans, acknowledging their role in improving both headache-related and psychological outcomes. More high-quality, multicenter randomized trials are needed to validate these findings and enhance treatment protocols for migraine sufferers.
References
1. Steiner, T.J., Stovner, L.J. Global epidemiology of migraine and its implications for public health and health policy. Nat Rev Neurol 19, 109–117 (2023). https://doi.org/10.1038/s41582-022-00763-1.
2. Amiri P, Kazeminasab S, Nejadghaderi SA, Mohammadinasab R, Pourfathi H, Araj-Khodaei M, Sullman MJM, Kolahi AA, Safiri S. Migraine: A Review on Its History, Global Epidemiology, Risk Factors, and Comorbidities. Front Neurol. 2022 Feb 23;12:800605. doi: 10.3389/fneur.2021.800605
3. Pellesi, L., Do, T. P., & Hougaard, A. (2024). Pharmacological management of migraine: current strategies and future directions. Expert Opinion on Pharmacotherapy, 25(6), 673–683. https://doi.org/10.1080/14656566.2024.2349791
4. Patel PS, Minen MT. Complementary and Integrative Health Treatments for Migraine. J Neuroophthalmol. 2019 Sep;39(3):360-369. doi: 10.1097/WNO.0000000000000841.
5. Hofmann SG, Gómez AF. Mindfulness-Based Interventions for Anxiety and Depression. Psychiatr Clin North Am. 2017 Dec;40(4):739-749. doi: 10.1016/j.psc.2017.08.008.
6. Shi Y, Wu W. Multimodal non-invasive non-pharmacological therapies for chronic pain: mechanisms and progress. BMC Med. 2023 Sep 29;21(1):372. doi: 10.1186/s12916-023-03076-2
7. La Touche R, de Oliveira AB, Paris-Alemany A, Reina-Varona Á. Incorporating Therapeutic Education and Exercise in Migraine Management: A Biobehavioral Approach. J Clin Med. 2024 Oct 21;13(20):6273. doi: 10.3390/jcm13206273.
8. Agbetou M, Adoukonou T. Lifestyle Modifications for Migraine Management. Front Neurol. 2022 Mar 18;13:719467. doi: 10.3389/fneur.2022.719467
9. Vekhter D, Robbins MS, Minen M, Buse DC. Efficacy and Feasibility of Behavioral Treatments for Migraine, Headache, and Pain in the Acute Care Setting. Curr Pain Headache Rep. 2020 Sep 26;24(10):66. doi: 10.1007/s11916-020-00899-z.
10. Wells RE, Seng EK, Edwards RR, Victorson DE, Pierce CR, Rosenberg L, Napadow V, Schuman-Olivier Z. Mindfulness in migraine: A narrative review. Expert Rev Neurother. 2020 Mar;20(3):207-225. doi: 10.1080/14737175.2020.1715212.
11. Cascade E, Kalali AH, Smitherman TA. Treatment of migraine and the role of psychiatric medications. Psychiatry (Edgmont). 2008 Oct;5(10):20-2.
12. Bae JY, Sung HK, Kwon NY, Go HY, Kim TJ, Shin SM, Lee S. Cognitive Behavioral Therapy for Migraine Headache: A Systematic Review and Meta-Analysis. Medicina (Kaunas). 2021 Dec 28;58(1):44. doi: 10.3390/medicina58010044.
13. Singer AB, Buse DC, Seng EK. Behavioral treatments for migraine management: useful at each step of migraine care. Curr Neurol Neurosci Rep. (2015) 15:14. doi: 10.1007/s11910-015-0533-5
14. Martin PR. Behavioral management of migraine headache triggers: learning to cope with triggers. Curr Pain Headache Rep. (2010) 14:221–7. doi: 10.1007/s11916-010-0112-z
15. Smitherman TA, Kuka AJ, Calhoun AH, Walters ABP, Davis-Martin RE, Ambrose CE et al. Cognitive-Behavioral therapy for insomnia to reduce chronic migraine: a sequential bayesian analysis. Headache. (2018) 58:1052–9. doi: 10.1111/head.13313
16. Kropp P, Meyer B, Meyer W, Dresler T. An update on behavioral treatments in migraine - current knowledge and future options. Expert Rev Neurother. (2017) 17:1059–68. doi: 10.1080/14737175.2017.1377611
17. Napadow V. The mindful migraine: does mindfulness-based stress reduction relieve episodic migraine? Pain. 2020 Aug;161(8):1685-1687. doi: 10.1097/j.pain.0000000000001859.
18. Wells RE, O’Connell N, Pierce CR, et al. Effectiveness of Mindfulness Meditation vs Headache Education for Adults With Migraine: A Randomized Clinical Trial. JAMA Intern Med. 2021;181(3):317–328. doi:10.1001/jamainternmed.2020.7090
19. Anheyer .D., Leach M.J., Klose .P ., Dobos .G and Cramer .H (2019) Mindfulness-based stress reduction for treating chronic headache: A systematic review and meta-analysis. Cephalalgia Vol 39, Issue 4 DOI:10.1177/0333102418781795
20. Bakhshani, Nour Mohammad & Amirani, Ahmadreza & Amirifard, Hamed & Shahrakipoor, Mahnaz. (2015). The Effectiveness of Mindfulness-Based Stress Reduction on Perceived Pain Intensity and Quality of Life in Patients With Chronic Headache. Global Journal of Health Science. 8. 10.5539/gjhs.v8n4p142
21. Sophia Prohaska, Katja Matthias; Effectiveness of Mindfulness-Based Stress Reduction as a Nondrug Preventive Intervention in Patients with Migraine: A Systematic Review with Meta-Analyses. Complement Med Res 28 December 2023; 30 (6): 525–534.
22. Pellesi L, Garcia-Azorin D, Rubio-Beltrán E, Ha WS, Messina R, Ornello R, Petrusic I, Raffaelli B, Labastida-Ramirez A, Ruscheweyh R, Tana C, Vuralli D, Waliszewska-Prosół M, Wang W, Wells-Gatnik W. Combining treatments for migraine prophylaxis: the state-of-the-art. J Headache Pain. 2024 Dec 5;25(1):214. doi: 10.1186/s10194-024-01925-w. Erratum in: J Headache Pain. 2025 Apr 3;26(1):66. doi: 10.1186/s10194-025-02007-1.
23. Dresler, T., Caratozzolo, S., Guldolf, K. et al. Understanding the nature of psychiatric comorbidity in migraine: a systematic review focused on interactions and treatment implications. J Headache Pain 20, 51 (2019). https://doi.org/10.1186/s10194-019-0988-x
24. Ornello, Raffaele et al. Resistant and refractory migraine: clinical presentation, pathophysiology and management eBioMedicine, Volume 99, 104943
25. Russo, M.; De Rosa, M.A.; Calisi, D.; Consoli, S.; Evangelista, G.; Dono, F.; Santilli, M.; Granzotto, A.; Onofrj, M.; Sensi, S.L. Migraine Pharmacological Treatment and Cognitive Impairment: Risks and Benefits. Int. J. Mol. Sci. 2022, 23, 11418. https://doi.org/10.3390/ijms231911418
Downloads
Published
Issue
Section
License
Copyright (c) 2025 American Journal of Psychiatric Rehabilitation
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 International License permitting all use, distribution, and reproduction in any medium, provided the work is properly cited.
